view kmb fundament improv evidenc
better-than-expect organ sale growth incl
consum product develop emerg market
ep beat addit top-lin strength
margin improv gross/ebit margin
y/i improv vs y/i us
suggest price stick least like aid
innov commod pressur clearli eas
favor read-through pg well although
continu think pg broadli out-execut said
kmb fundament improv see current environ
somewhat unsustain think promo like increas
across kmb key care/consum tissu categori input
cost pressur remain benign encourag
kmb momentum believ mgmt updat guidanc
doabl incl organ sale growth y/i vs prior
ep vs see upsid
limit all-in flow today ep beat increas
ep estim increas
price target said maintain market
perform rate see limit upsid current level
result strong organ sale growth kmb
adj ep y/i well ahead estimate /con
although note ep also benefit sever
equiti incom kmb organ sale growth much
better-than-expect driven price our/street
est takeaway incl develop
 emerg organ sale growth strong impress
sequenti improv north
america na consum product organ sale growth also
strong sequenti acceler vs
overal price resili although volume growth flat
elsewher ebit margin y/i consum
tissu ebit margin robust y/i forc
focus reduc cost everywher
off-set higher input cost although importantli input
cost pressur moder sequenti
gross margin ahead expect gross margin
y/i ahead estim
commod y/i headwind includ pulp
inflat fx reduc oper profit
larg off-set cost save includ forc
focus reduc cost everywher save
estim restructur save advertis
spend higher y/i increas digit spend cost
pressur increas compens drive market
research y/i overal ebit margin
y/i in-lin estim
pleas see page rate definit import disclosur
requir analyst certif estimates/forecast
well fargo secur llc seek busi compani
cover research report result investor awar
firm may conflict interest could affect object report
investor consid report singl factor make
compani data secur llc estim reuter
exclud restructur charg one-tim item
compani data secur llc estim reuter
ep expect report ep y/i
well ahead our/consensu estim
kmb solid organ sale also expect organ sale growth
our/consensu estim organ sale growth driven entir price
volum slightli mix/oth develop emerg market
organ sale growth strong north america consum product organ sale
growth y/i segment organ sale growth follow vs
estim consum tissu vs estim k-c profession
vs estim
develop emerg market growth continu acceler organ sale growth
improv strongest growth market year sinc
note organ sale growth includ boost argentina
take signific price strong market includ brazil dd behind higher price china
dd vs easi y/i comparison strong growth fem
strong organ sale growth ahead expect net
sell price volum product mix partial off-set fx
headwind drive overal sale increas north america sale
balanc split price volum volum lsd babi child
continu hsd adult behind innov brand invest categori
growth fem volum north america -msd look forward launch huggi
special deliveri juli super-premium diaper made plant-bas materi
consum tissu organ sale growth solid slightli
estim net sell price solid partial off-set volum declin
product mix slightli overal sale flat fx reduc sale growth
north america organ sale net sell price partial off-set
volum declin
k-c profession organ sale growth estim net
sell price product mix improv offset declin volum fx
headwind busi exit drag top-lin caus sale declin
north america organ sale growth price fulli off-set headwind
busi exit
gross margin ahead expect gross margin y/i
ahead estim commod y/i headwind includ
pulp inflat fx reduc oper profit larg off-set cost save
includ focus reduc cost everywher save
estim restructur save advertis spend higher y/i
increas digit spend cost pressur increas compens drive
market research y/i overal ebit margin y/i
in-lin estim
rais guidanc across board follow better-than-expect manag
rais guidanc adjust includ higher organ sale growth volume-driven lower
organ sale develop emerg market organ sale corpor
commod headwind partial off-set higher reinvest behind advertis commerci
capabl employe comp adjust ep expect vs prior
compar compon guidanc includ
net sale expect flat prior includ increas
organ sale growth prior
adjust oper profit growth expect prior save
expect partial off-set input cost inflat prior
million outlook pulp superabsorb polym resin improv
higher market sg expens previous expect
favor read-through pg overal view kmb result favor read-through pg
earn given better-than-expect organ sale growth strong price power
bode well pg price action also think pg like out-execut sever
key market particularli china kmb volum still neg like reflect part
continu share loss key competitor incl pg
guidanc medium-term outlook
k-c strategi medium term objectivesour est growthup sale growthup line ep provid januari call april call jul call fy sale sale impact impact profitsadj op profit growth ex-charg allocationcapit share repurchas share repurchas dividend itemsinput pulp per metric ton eucalyptu per barrel save global restructur forc interest expenseincreas somewhat y/yincreas somewhat vs vs incom equiti companiessimilar y/ysimilar y/yhigh vs vs lycash operationsdown slightli y/ydown slightli y/ydown slightli vs vs lyfi guidanc cosmet household person
guidanc provid januari call april call juli call oct call fy sale sale py/up slightli y/yslightli higher previous assumedmodestli posit posit impact salesneutr impact sale profitsadj op profit high end slightli growth ex-charg allocationcapit total capit allocationshar repurchas share repurchas defin benefit pension contributionsdividend itemsinput half rang pulp per metric y/yoil per y/ysav global restructur interest vs low incom equiti companiessimilar slightli vs lycash vs lyfi guidanc corpor
chart compani report secur llc estim
volum price mix/oth organ sale growth margin net sale rh chang gross margin bp lh y/i chang bp net margin net sale rh chang oper margin bp lh y/i chang bp net incom growth y/i chang oper incom growth y/i chang ex fx y/i chang y/i chang ep y/i chang ex fx y/i chang lh ep growth y/i chang rh ep growth y/i chang ex fx rh cosmet household person
chart compani report secur llc estim
volum price mix/oth organ sale growth margin net sale rh chang oper margin bp lh y/i chang bp net volum price mix/oth organ sale growth margin net sale rh chang oper margin bp lh y/i chang bp net volum price mix/oth organ sale growth margin net sale rh chang oper margin bp lh y/i chang bp net sale corpor
one largest consum product compani world strong portfolio highli
recogniz brand kleenex scott huggi pull-up kotex depend given strong
foothold mani key develop emerg market believ well posit capit
long-term expans growth spend power global middl class addit
optimist benefit long-term growth tailwind key categori adult
incontin matur develop market like unit state well emerg market
china continu gener cost save introduc greater level effici across
global oper particularli within suppli chain expect continu work
supplier upstream innov develop product value-accret compani
end user simultan lower input cost howev sever pressur could continu limit
kmb near-term growth opportun bottom line still see multipl pressur point kmb
busi believ prudent investor remain sidelin
price target base follow methodolog forward ev-to-ebitda price-to-earnings
analysi absolut rel discount analysi
forward ev-to-ebitda absolut rel current trade
ev/ebitda multipl premium compani histor averag
multipl premium compani histor averag multipl
price target impli ev/ebitda multipl discount
compani current ev/ebitda multipl premium histor averag
multipl premium histor averag multipl furthermor current
trade discount rel hpc peer group forward ev/ebitda multipl basi
compar discount hpc group histor averag forward ev/ebitda
basi discount hpc group histor averag forward ev/ebitda basi
forward price-to-earnings absolut rel current trade price-to-earnings multipl
premium compani histor averag multipl
premium compani histor averag multipl price target impli
price-to-earnings multipl discount compani current price-to-earnings multipl
premium histor averag multipl premium histor
averag multipl furthermor current trade discount rel hpc peer
group forward price-to-earnings multipl basi compar discount hpc group
year histor averag forward price-to-earnings basi discount hpc group histor
sum-of-the-part discount also valu base sum-of-the-part dcf
analysi better understand compani growth opportun particularli person
k-c profession base analysi believ worth
segment worth consum tissu segment worth k-c
chart factset secur llc
chart factset secur llc
chart factset secur llc
multipl pt spreadabsolut performancerel perform spreadwidest posit spread neg spread ntm stapl spreadwidest posit spread neg spread rel yr rel rel consum stapl pt spread rel yr pt spread rel pt spread rel consum stapl
chart factset secur llc
multipl pt spreadabsolut performancerel perform spreadhistor ev/ebitda stapl spreadhist rel yr rel rel consum stapl pt spread rel yr pt spread rel pt spread rel consum stapl corpor
compani report secur llc estim
good sold- profit- research a- incom expens net- income- income- taxes- rate- equiti interests- net incom equiti companies- interest- income- eps- per net tissu net profession net sale ex research incom ex currenc incom k-c ep ex cosmet household person
compani report secur llc estim
revenu build unless l/c organ sale growth america consum sale profession sale ex-curr net sale incom total segment oper incom expens net- oper ex-charg sale growth sale growth ex-curr incom growth total segment oper net sale excl interseg incom segment oper incom segment oper margin corpor
volum average price/unit growth y/i
dollar share y/i chang
chart tabl nielsen xaoc includ c-store secur llc
sale y/yeq sale y/yavg eq price y/i sold promo sold promo y/ydollar sharedollar share y/i bp retailperiod end end end end end end end channel data chang bp dollar share cosmet household person
note total organ sale growth data includ segment includ kc-profession across
geographi compani report nielsen xaoc includ c-store secur llc estim
note total person organ sale growth data includ geographi compani report
nielsen xaoc includ c-store secur llc estim
note total consum tissu organ sale growth data includ geographi compani report
nielsen xaoc includ c-store secur llc estim
categori result period end categori retail sale
note babi diaper china breakdown cover nielsen mass retail univers total china nation exclud
babi store babi diaper specialti breakdown babi store jf january/februari
nielsen scantrack total emerg market secur llc
emerg market valu sale volum average price per growth
nielsen scantrack total emerg market secur llc
emerg market valu share y/i chang
nielsen scantrack total emerg market secur llc
european summari data week end
european eq volum average price/eq growth
european valu share y/i chang
chart tabl nielsen esp total europ secur llc
chart risi includ forecast secur llc
privat label retail share across hpc weight lead brand hpc compani
note unilev hpc exclud unilev food categori analysi base retail share across track
channel
compani report nielsen total us xaoc includ conveni databas secur llc
price target
price target assum price-to-earnings ev-to-ebitda multipl risk price
target includ heighten competit pressur stronger dollar commod price volatil
changespot pricepricesappear come changespot pricepricesappear come hpcweightedaverageweightedaverag ex pg weight privat label share trail week changedecreaseincreasedecreaseincreaseincreaseincreaseincreasedecreaseslight increaseslight decreas cosmet household person
strong develop emerg market footprint appear well posit capit long-
term expans spend power global rise middl class howev emerg market
categori growth moder competit pressur intensifi cautiou near term
base dalla tx one largest consum product compani world
lead brand kleenex scott huggi pull-up kotex depend hold
share posit countri sale
busi year sell brand countri
pg thesi pg chang sens urgenc account infus
organ pg fundament improv compani gener consist result
see pg one stapl compani abl consist deliv
acceler organ sale growth time expand margin
